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Abstract
Background: Proliferation and apoptosis of mesangial cells (MC) are important mechanisms
during nephrogenesis, for the maintenance of glomerular homeostasis as well as in renal disease
and glomerular regeneration. Expression of chemokines and chemokine receptors by intrinsic renal
cells, e.g. SLC/CCL21 on podocytes and CCR7 on MC is suggested to play a pivotal role during
these processes. Therefore the effect of selected chemokines on MC proliferation and apoptosis
was studied.
Methods: Proliferation assays, cell death assays including cell cycle analysis, hoechst stain and
measurement of caspase-3 activity were performed.
Results: A dose-dependent, mesangioproliferative effect of the chemokine SLC/CCL21, which is
constitutively expressed on human podocytes was seen via activation of the chemokine receptor
CCR7, which is constitutively expressed on MC. In addition, in cultured MC SLC/CCL21 had a
protective effect on cell survival in Fas-mediated apoptosis. The CXCR3 ligands IP-10/CXCL10 and
Mig/CXCL9 revealed a proproliferative effect but did not influence apoptosis of MC. Both the
CCR1 ligand RANTES/CCL5 and the amino-terminally modified RANTES analogue Met-RANTES
which blocks CCR1 signalling had no effect on proliferation and apoptosis.
Conclusions: The different effects of chemokines and their respective receptors on proliferation
and apoptosis of MC suggest highly regulated, novel biological functions of chemokine/chemokine
receptor pairs in processes involved in renal inflammation, regeneration and glomerular
homeostasis.
Background
Originally chemokines (chemotactic cytokines) were
described as key mediators for the selective migration of
leukocytes into sites of tissue injury [1]. Later on chemok-
ines and chemokine receptors have also been described as
important mediators in noninflammatory processes,
including normal cellular trafficking, hematopoesis, ang-
iogenesis, organ development, tissue remodelling, and
tumor metastasis [2-4]. To date more than 40 different
human chemokines are characterized. The chemokine
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superfamily is separated into the C, CC, CXC, and CX3C
subfamilies (Where X represents any intervening amino
acid residue between the first two cysteines in the amino
acid sequence) [5,6]. Chemokines mediate their biologi-
cal activity by ligation and interaction with seven-trans-
membrane-spanning G protein-coupled receptors (i.e. C,
CC, CXC, and CX3C receptors) [7].
In the kidney expression of chemokines and chemokine
receptors are important for the initiation and regulation
of inflammatory glomerular diseases [8]. Expression of
the chemokines monocyte chemoattractant protein-1
(MCP-1/CCL2), regulated upon activation, normal T cell
expressed and secreted (RANTES/CCL5), interleukin-8
(IL-8), and interferon-γ (IFN-γ)-inducible protein of 10
kD (IP-10/CXCL10) by human mesangial cells (MC) was
shown by our group [9] and others [1,10]. Inducible
expression of the chemokine receptor CCR1 by human
MC was previously described [9]. The expression of the
chemokine receptor CXCR3 on human MC was published
by Romagnani and colleagues [11]. A high level of expres-
sion of this receptor by MC was seen by immunohisto-
chemistry in kidney biopsies from patients with IgA
nephropathy, membranoproliferative glomerulonephritis
or rapidly progressive glomerulonephritis. Recently our
group showed that SLC/CCL21 is constitutively expressed
by glomerular podocytes and CCR7 constitutively
expressed by MC [12].
In the kidney the well-regulated relationship among resi-
dent cell proliferation and apoptosis is important for the
development of the sophisticated glomerular architecture
during ontogenesis as well as maintaining normal func-
tion of adult human glomeruli. Dysfunction of the bal-
ance between glomerular cell proliferation and apoptosis
after leukocyte infiltration has been discussed for many
inflammatory kidney diseases [13].
The finding of expression of chemokine receptors and
their respective ligands by intrinsic renal cells not only
under inflammatory conditions led to the hypothesis of
an involvement of these receptors in glomerular homeos-
tasis. Therefore the influence of chemokines on mesangial
cell growth was investigated. We describe the different
effects of the chemokines SLC/CCL21, IP-10/CXCL10,
Mig/CXCL9, RANTES/CCL5 and the amino-terminally
modified RANTES/CCL5 analogue Met-RANTES on
mesangial cell proliferation and apoptosis, suggesting
novel functions of chemokine/chemokine receptor pairs
on local immunomodulation, glomerular regeneration
and homeostasis.
Methods
Cell culture conditions for human mesangial cells
Immortalized human mesangial cells (MC) were grown as
described previously [9]. This MC line was characterized
for antigenic markers typically expressed by MC in vivo
and  in vitro and showed no dedifferentiation within
approximately 100 passages during a 36 months cultiva-
tion period. For all experiments cells in passages 51 to 65
were used. Different preparations of primary human MC
served as controls and were cultured as previously
described [14].
Proliferation assay
To assess proliferation we performed a MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide,
Sigma, Germany) assay [15]. Aliquots of 20 × 103 cells in
100 µl medium were cultured in 96-well microtitre plates
for 24 hours under standard conditions to yield firmly
attached and stably growing cells. Subsequently the
medium was changed to 100 µl of medium containing
test substances and the cells were incubated from 24 to 72
hours. After discarding the supernatants 50 µl of a 1 mg/
ml solution of MTT were added. The cells were incubated
for 3 hours at 37°C and then formazan crystals were dis-
solved by addition of 50 µl isopropanol. Absorbance was
measured at 550 nm against 630 nm reference using a
DYNATECH (Germany) MR7000 ELISA reader. For each
experiment at least 6 wells were analyzed per experimen-
tal condition and time point.
Cell death assays
Apoptosis of MC was induced by Fas/CD 95 ligation as
previously described [16]. Fas/CD 95 surface expression
was induced by starvation of the cells in serum-free
medium and pre-stimulation with IFN-γ (70 ng/ml) for
48 h. For analysis of chemokine effects, cells were pre-
treated with SLC/CCL21 250 ng/ml, IP-10/CXCL10 100
ng/ml, Mig/CXCL9 100 ng/ml, RANTES/CCL5 100 ng/ml,
and Met-RANTES 100 ng/ml prior to adding the activating
anti-human Fas antibody (400 ng/ml, incubation over 18
hours) (Biomol, Germany). To induce expression of the
chemokine receptor CCR1 in a different experiment MC
were preincubated with a combination of IFN-γ (20 ng/
ml), TNF-α (25 ng/ml) and IL-1β (10 ng/ml) for 24 h
before starvation of the cells in serum-free medium and
stimulation with IFN-γ (70 ng/ml), TNF-α (25 ng/ml) and
IL-1β (10 ng/ml) for 48 h. Apoptosis was studied with sev-
eral assays: Flow cytometric cell cycle analysis was per-
formed using propidium iodide staining as described
previously [17]. For visualization of chromatin fragmen-
tation, MC were seeded on chamber slides (NUNC, Ger-
many). After treatment with test substances cells were
fixed with ethanol and stained with the nuclear dye
Hoechst 33258 (Hoechst, Germany) 5 µmol/ml. The per-
centage of apoptotic cells was determined byBMC Nephrology 2004, 5:8 http://www.biomedcentral.com/1471-2369/5/8
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immunofluorescence microscopy, counting nuclei with
condensed and fragmented chromatin. Three different
experiments were performed, at least 300 cells were ana-
lyzed per condition. Counting was performed in a blinded
manner by two investigators. For measurement of cas-
pase-3 activity [18] a commercial assay (R&D systems,
Germany) was used according to the manufacturer's spec-
ifications. After induction of apoptosis as described
above, MC were lysed and caspase-3 specific proteolytic
activity was quantitated spectrophotometrically. Three
experiments were done analyzing duplicates for any
experimental condition.
Statistical analysis
Values are provided as mean ± SEM. Statistical analysis
was performed by unpaired t test. Significant differences
are indicated for p values < 0.05 (*) or < 0.01 (**),
respectively.
Results
Effects of SLC/CCL21, IP-10/CXCL10, Mig/CXCL9, 
RANTES/CCL5 and Met-RANTES on proliferation of 
human mesangial cells
SLC/CCL21 induces proliferation of human MC
To demonstrate that activation of CCR7 has an influence
on the proliferative activity of MC MTT assays were per-
formed as described in Methods. The CCR7 ligand SLC/
CCL21 led to a concentration dependent increase of pro-
liferation of human MC in a range from 10 to 250 ng/ml
after 24 hours of stimulation (Figure 1A). In a time course
experiment from 24 to 72 hours the maximum increase of
proliferation was seen after incubation with SLC/CCL21
for 48 hours (Figure 1B).
IP-10/CXCL10 and Mig/CXCL9 induce proliferation of human MC
CXCR3 activation had an influence on the proliferative
activity of MC. As shown in Figure 2, stimulation with the
CXCR3 ligands IP-10/CXCL10 and Mig/CXCL9 had an
increasing effect on the proliferation of human MC in
concentrations 10 to 250 ng/ml (Figure 2). Incubation
period was 24 hours.
RANTES/CCL5 and Met-RANTES have no effect on proliferation of 
human MC
Incubation of human MC with various concentrations of
the CCR1 ligands RANTES/CCL5 (10 ng/ml, 50 ng/ml,
100 ng/ml, 250 ng/ml) and Met-RANTES (10 ng/ml, 50
ng/ml, 100 ng/ml, 250 ng/ml) had no effect on the prolif-
eration of MC at an incubation period of 24 hours under
standard conditions (Figure 3). To induce chemokine
receptor CCR1 expression cells were pretreated with a
combination of IFN-γ (20 ng/ml), TNF-α (25 ng/ml) and
IL-1β (10 ng/ml) for 24 hours prior to adding test sub-
stances. Stimulation with RANTES/CCL5 or Met-RANTES
without pretreatment with cytokines has no effect on pro-
liferation (data not shown).
Effects of SLC/CCL21, IP-10/CXCL10, Mig/CXCL9, 
RANTES/CCL5 and Met-RANTES on apoptosis of human 
mesangial cells
SLC/CCL21 has an anti-apoptotic effect on Fas/CD95-induced 
apoptosis
The effect of CCR7 activation for MC survival in Fas/
CD95-induced cell death was studied with three different
methods. Flow cytometric cell cycle analysis using propid-
ium iodide staining showed 8.3 ± 1.1% apoptotic cells
under normal conditions. After serum-starvation and
incubation with IFN-γ for 48 hours human MC express
Fas/CD95 on surface (data not shown). Under these con-
ditions the population with a sub-G1 DNA content was
20.4 ± 3.6% (Figure 4A). Serum-starvation and stimula-
tion with IFN-γ showed no difference in the number of
apoptotic MC compared to serum-starvation without
stimulation with IFN-γ (data not shown). Subsequent
stimulation with an activating anti-Fas antibody increased
the amount of MC with a sub-G1 DNA content to 50.1 ±
3.6% consistent with a marked increases in apoptosis
(Figure 4B). When MC were prestimulated with SLC/
CCL21 prior to induction of cell death the percentage of
apoptotic cells was reduced markedly to 31.2 ± 4.4% (Fig-
ure 4C). The results are from four independent experi-
mental series. The data are shown in Table 1. Staining
with Hoechst visualizes cells with fragmented chromatin.
Figure 5 shows a fluorescent microscopic analysis of MC.
Figure 5A represents cells stimulated with IFN-γ and Fig-
ure 5B cells stimulated with IFN-γ and Fas ligation. Figure
5C shows a significantly reduced number of apoptotic
cells when MC were prestimulated with SLC/CCL21 prior
to induction of cell death. Apoptotic nuclei were analyzed
microscopically in three different sets of experiments
counting at least 300 cells per condition. After serum star-
vation and IFN-γ stimulation 9.4 ± 2.5% of the cells were
found to be apoptotic. Subsequent Fas ligation induced
apoptosis in 37.3 ± 3.2% of human MC. Prestimulation
with SLC/CCL21 reduced Fas-induced cell death effec-
tively to 15.0 ± 2.6% (Figure 6A). Induction of cell death
of MC by Fas ligation increased Caspase-3 activity 2.8-fold
compared with control conditions. Coincubation with
SLC/CCL21 reduced caspase-3 activity significantly (Fig-
ure 6B)
IP-10/CXCL10 and Mig/CXCL9 have no effect on Fas/CD95-induced 
cell death of human MC
To investigate the effect of the CXCR3 ligands IP-10/
CXCL10 and Mig/CXCL9 on Fas-induced cell death MC
were grown without serum and stimulated with IFN-γ.
Induction of cell death by an activating anti-Fas-antibody
led to significantly increased number of apoptotic cells.BMC Nephrology 2004, 5:8 http://www.biomedcentral.com/1471-2369/5/8
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Dose- and time- dependent effect of SLC/CCL21 on proliferation of human MC Figure 1
Dose- and time- dependent effect of SLC/CCL21 on proliferation of human MC. (A) Incubation of human MC with various 
concentrations of SLC/CCL21 (10 ng/ml, 50 ng/ml, 100 ng/ml, 250 ng/ml) induces proliferation of MC in a dose-dependent 
manner. (B) Time-course stimulation of MC with SLC/CCL21 for various time intervals (24 h, 48 h, 72 h). Cell proliferation 
was analyzed with the MTT assay as described in Methods. Cells growing under standard conditions served as control. 
Changes in proliferative activity are given as relative values to the respective controls. Each bar represents a mean ± SEM of 7 
parallel incubations for each condition. Statistically significant differences to the control are depicted with * = p < 0.05 and ** = 
p < 0.01, resp. Comparable results were obtained in three series of independent experiments.BMC Nephrology 2004, 5:8 http://www.biomedcentral.com/1471-2369/5/8
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Dose-dependent effect of IP-10/CXCL10 and Mig/CXCL9 on proliferation of human MC Incubation of human MC for 24 hours  with various concentrations of IP-10/CXCL10 and Mig/CXCL9 (10 ng/ml, 100 ng/ml, 250 ng/ml) induces proliferation of MC in  a dose-dependent manner Figure 2
Dose-dependent effect of IP-10/CXCL10 and Mig/CXCL9 on proliferation of human MCIncubation of human MC for 24 hours 
with various concentrations of IP-10/CXCL10 and Mig/CXCL9 (10 ng/ml, 100 ng/ml, 250 ng/ml) induces proliferation of MC in 
a dose-dependent manner. Cell proliferation was analyzed with the MTT assay as described in Methods. Cells growing under 
standard conditions served as control. Changes in proliferative activity are given as relative values to the respective controls. 
Each bar represents a mean ± SEM of 5 parallel incubations for each condition. Statistically significant differences to the control 
are depicted with * = p < 0.05 and ** = p < 0.01, resp. Comparable results were obtained in three series of independent 
experiments.BMC Nephrology 2004, 5:8 http://www.biomedcentral.com/1471-2369/5/8
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Effect of RANTES/CCL5 and Met-RANTES on proliferation of human MC Incubation of human MC for 24 hours with various  concentrations of RANTES/CCL5 (10 ng/ml, 100 ng/ml, 250 ng/ml, 1 µg/ml, 10 µg/ml) and Met-RANTES (10 ng/ml, 100 ng/ml,  250 ng/ml, 1 µg/ml, 10 µg/ml) has no effect on proliferation of MC under standard conditions Figure 3
Effect of RANTES/CCL5 and Met-RANTES on proliferation of human MCIncubation of human MC for 24 hours with various 
concentrations of RANTES/CCL5 (10 ng/ml, 100 ng/ml, 250 ng/ml, 1 µg/ml, 10 µg/ml) and Met-RANTES (10 ng/ml, 100 ng/ml, 
250 ng/ml, 1 µg/ml, 10 µg/ml) has no effect on proliferation of MC under standard conditions. To induce expression of chem-
okine receptor CCR1 MC were prestimulated with IFN-γ (20 ng/ml), TNF-α (25 ng/ml) and IL-1β (10 ng/ml) for 24 hours prior 
to adding test substances. Cell proliferation was analyzed with the MTT assay as described in Methods. Cells growing under 
standard conditions served as control. Changes in proliferative activity are given as relative values to the respective controls. 
Each bar represents a mean ± SEM of 7 parallel incubations for each condition. Comparable results were obtained in three 
series of independent experiments.BMC Nephrology 2004, 5:8 http://www.biomedcentral.com/1471-2369/5/8
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Coincubation with IP-10/CXCL10 or Mig/CXCL9 had no
effect on Fas-induced apoptosis of MC (Figure 7). The
data of four separate experiments are shown in Table 1.
RANTES/CCL5 and Met-RANTES have no effect on Fas/CD95-
induced cell death of human MC
To induce expression of chemokine receptor CCR1 cells
were pretreated with a combination of IFN-γ (20 ng/ml),
TNF-α (25 ng/ml) and IL-1β (10 ng/ml) for 24 hours, fol-
Effect of SLC/CCL21 on Fas-induced cell death of human MC in cell cycle analysis by flow cytometry Figure 4
Effect of SLC/CCL21 on Fas-induced cell death of human MC in cell cycle analysis by flow cytometry. Percentage of apoptotic 
cells was analyzed in cell cycle analysis by flow cytometry after staining with propidium iodide. Histograms represent cell 
counts (y-axis) versus DNA content (x-axis) with the percentage of apoptotic cells containing sub-G1 DNA indicated. Figure 
4A shows the cell cycle analysis of MC after serum starvation and stimulation with IFN-γ for 48 hours. Figure 4B: Apoptosis 
was induced subsequently by Fas ligation. Figure 4C: Effect of preincubation with SLC/CCL21 250 ng/ml on Fas-induced apop-
tosis of MC. The profiles shown are representative for four independent experiments.BMC Nephrology 2004, 5:8 http://www.biomedcentral.com/1471-2369/5/8
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lowed by serum-starvation and incubation with IFN-γ for
48 hours (Figure 8A). Cell death was induced again by
stimulation with an activating anti-Fas antibody (Figure
8B). Stimulation with RANTES/CCL5 (250 ng/ml) (Figure
8C) or Met-RANTES (250 ng/ml) (Figure 8D) prior to
induction of cell death was ineffective in maintaining cell
survival. The results are from four independent experi-
mental series (See Table 1). The percentage of apoptotic
cells varies between the experiments due to biological
variance.
Discussion
Proliferation and apoptosis play a pivotal role in a variety
of biological processes, such as morphogenesis during the
embryonic stage, cell selection during lymphoid develop-
ment, tissue repair after injury, regression of inflamma-
tion, elimination of cells at risk of developing into a
tumor and lymphocyte-mediated killing [19]. A balance
of proliferation and apoptosis is essential for the tissue
homeostasis [20,21].
Apoptosis as mechanism of controlled cell death is a well-
controlled process and progresses through a series of mor-
phological and biochemical phases, including chromatin
condensation and activation of proteolytic enzymes
[22,23]. A number of mediators involved in the induction
of apoptosis have been identified during recent years.
Probably the most thoroughly characterized death recep-
tor is the cell membrane receptor Fas (CD 95), a member
of the TNF receptor family. Cross-linking of Fas, either via
specific antibodies or via its specific ligand, activates a
cascade reaction of caspases, which are responsible for
induction of membrane alterations, breakdown of cellu-
lar constituents and DNA, and finally cell death [19].
In the kidney beside the damage induced by infiltrating
inflammatory cells the relationship among resident cell
proliferation and apoptosis in glomeruli determines the
outcome in various glomerulonephritides [13]. Several
groups reported that apoptosis plays an important role in
Table 1: Effect of SLC/CCL21, IP-10/CXCL10, Mig/CXCL9, RANTES/CCL5 and Met-RANTES on Fas-induced cell death of human 
mesangial cells.
IFN IFN/aFas IFN/aFas/ 
SLC
IFN IFN/aFas IFN/aFas/
IP-10
IFN/
aFas/Mig
IFN IFN/aFas IFN/aFas/
RANTES
IFN/aFas/Met-
RANTES
15.8 47.2 24.7 11.1 36.7 21.1 25.8 18.3 40.9 31.6 35.5
22.4 53.1 33.7 16.3 33.1 25.3 28.2 19.3 34.1 40.7 41.8
23.9 53.4 34.1 20.2 29.9 28.7 28.9 24.8 46.2 39.6 35.5
19.6 46.8 32.4 13.5 25.9 31.1 36.3 16.2 37.9 34.2 42.6
Mean 20.4 50.1 31.2 15.3 31.4 26.6 29.8 19.7 39.8 36.5 38.1
SEM 3.6 3.6 4.4 3.9 4.6 4.3 4.5 3.7 5.1 4.3 4.9
Data of four separate FACS analyses, respectively. Values are means ± SEM.
Effect of SLC/CCL21 on Fas-induced cell death of human MC  in Hoechst stain on a fluorescent microscopic analysis of MC  (A) MC stimulated with IFN-γ Figure 5
Effect of SLC/CCL21 on Fas-induced cell death of human MC 
in Hoechst stain on a fluorescent microscopic analysis of MC 
(A) MC stimulated with IFN-γ. (B) MC stimulated wit IFN-γ 
and Fas ligation. (C) Significantly reduced number of apop-
totic cells when MC were prestimulated with SLC/CCL21 
prior to induction of cell death.BMC Nephrology 2004, 5:8 http://www.biomedcentral.com/1471-2369/5/8
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Effect of SLC/CCL21 on Fas-induced cell death of human MC in cell count and caspase-3 assay Figure 6
Effect of SLC/CCL21 on Fas-induced cell death of human MC in cell count and caspase-3 assay. (A) The percentage of apop-
totic MC was determined after visualisation of fragmented chromatin with Hoechst dye. Apoptotic nuclei were analyzed 
microscopically in three different sets of experiments counting at least 300 cells per condition. (B) Caspase-3 activity was quan-
titated spectrophotometrically in MC lysates. Data are from three independent sets of experiments, each performed in dupli-
cate. Statistically significant differences are depicted: * = p < 0.05 and ** = p < 0.01, resp.BMC Nephrology 2004, 5:8 http://www.biomedcentral.com/1471-2369/5/8
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the repair process in experimental and human glomeru-
lonephritis [24,25]. Apoptosis has an additional role in
the sclerosing process in the glomeruli [26]. Cell number
abnormalities are frequent in renal diseases, and range
from the hypercellularity of postinfectious glomerulone-
phritis to the cell depletion of chronic renal atrophy.
Effect of IP-10/CXCL10 and Mig/CXCL9 on Fas-induced cell death of human MC in cell cycle analysis by flow cytometry Figure 7
Effect of IP-10/CXCL10 and Mig/CXCL9 on Fas-induced cell death of human MC in cell cycle analysis by flow cytometry. Per-
centage of apoptotic cells was analyzed in cell cycle analysis by flow cytometry after staining with propidium iodide. Histograms 
represent cell counts (y-axis) versus DNA content (x-axis) with the percentage of apoptotic cells containing sub-G1 DNA indi-
cated. Cell cycle analysis of MC was performed after serum starvation and stimulation with IFN-γ for 48 hours. (A) Cell cycle 
analysis of MC after serum starvation and stimulation with IFN-γ for 48 hours. (B) Apoptosis was induced subsequently by Fas 
ligation. (C, D) Preincubation with IP-10/CXCL10 and Mig/CXCL9 has no effect on Fas-induced apoptosis of MC. The profiles 
shown are representative for four independent experiments.BMC Nephrology 2004, 5:8 http://www.biomedcentral.com/1471-2369/5/8
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Death ligands and receptors, such as TNF and Fas-ligand,
pro-apoptotic and anti-apoptotic Bcl-2 family members
and caspases have all been shown to participate in apop-
tosis regulation in the course of renal injury [27]. Some
reports suggest that altered apoptotic signaling and regu-
latory mechanisms contribute to further progressive renal
impairment, tubular atrophy, interstitial fibrosis, and
Effect of RANTES/CCL5 and Met-RANTES on Fas-induced cell death of human MC in cell cycle analysis by flow cytometry Figure 8
Effect of RANTES/CCL5 and Met-RANTES on Fas-induced cell death of human MC in cell cycle analysis by flow cytometry. 
Percentage of apoptotic cells was analyzed in cell cycle analysis by flow cytometry after staining with propidium iodide. Histo-
grams represent cell counts (y-axis) versus DNA content (x-axis) with the percentage of apoptotic cells containing sub-G1 
DNA indicated. (A) Cell cycle analysis of MC was performed after serum starvation and stimulation with IFN-γ for 48 hours. 
(B) Apoptosis was induced subsequently by Fas ligation. Prior to serum starvation the expression of chemokine receptor 
CCR1 was induced by pretreatment with a combination of IFN-γ (20 ng/ml), TNF-α (25 ng/ml) and IL-1β (10 ng/ml) for 24 
hours. (C,D) RANTES/CCL5 250 ng/ml and Met-RANTES 250 ng/ml have no effect on Fas-induced cell death of MC.BMC Nephrology 2004, 5:8 http://www.biomedcentral.com/1471-2369/5/8
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glomerulosclerosis in a model of focal and segmental
glomerulosclerosis in rats [28].
In the glomerulus a balance between endothelial,
mesangial and visceral epithelial cells and their extracellu-
lar matrix is essential for structural and functional integ-
rity. During glomerular injury function and morphology
of these cells are altered. Intrinsic cell proliferation in the
glomerulus is regulated by a large number of mediators
and growth factors like IL-10 [29], insulin-like growth fac-
tors [30] and platelet derived growth factor [31]. Some of
these factors also influence apoptosis in the glomerulus
[32].
The basis for the experiments performed in this work was
the hypothesis that chemokines and chemokine receptors
expressed by intrinsic renal cells may be involved both in
the maintenance of glomerular homeostasis in normal
adult human kidney and regulation of glomerular cell
numbers during disease states. We previously showed
constitutive expression of CCR7 protein and its ligand sec-
ondary lymphoid tissue chemokine (SLC/CCL21) in
human renal tissue. In immunohistochemistry we found
a clear staining pattern for SLC/CCL21 on podocytes and
CCR7 on MC during nephrogenesis and in adult kidney.
Also constitutive mRNA expression has been shown for
CCR7 in cultured MC and for SLC/CCL21 in isolated
human glomeruli. Furthermore it was demonstrated that
mesangial CCR7 is functionally active since for example
SCL/CCL21 induced a dose-dependent migration of MC
[12]. We therefore investigated the influence of chemok-
ines on MC growth and found an significant increase in
proliferation of MC after stimulation with SLC/CCL21 in
a dose-dependent manner. To study the role of SLC/
CCL21 in MC apoptosis cell death was induced by activat-
ing mesangial Fas/CD95 receptors. SLC/CCL21 was found
to prevent MC apoptosis as shown by cell cycle analysis
and Hoechst stain. Since caspase-3 assays revealed
impaired activity it can be assumed that this molecule is
involved in chemokine-influenced intracellular apoptosis
pathways in MC. The finding of an anti-apoptotic func-
tion of SLC/CCL21 is novel. At present SLC/CCL21 is
known to be constitutively produced by high endothelial
venules and stromal cells within T cell zones of lymph
nodes [33]. Its corresponding receptor CCR7 is expressed
on naive T cell subpopulations and up-regulated by
maturing dendritic cells [34]. Therefore this chemokine/
chemokine receptor pair was described as an prototypic
model for the homing of immune cells to lymphoid tissue
[35,36]. Anti-apoptotic effects of chemokines seem not to
be restricted to SLC/CCL21. The CX3CR1-binding chem-
okine fractalkine which is constitutively expressed on neu-
ronal cells has been demonstrated as survival factor for
brain microglia in Fas-induced cell death [37].
A role of the chemokine receptor CXCR3 in inflammatory
glomerular disease has been proposed before by the group
of Romagnani et al. since a mesangial expression of
CXCR3 in biopsies from patients with mesangioprolifera-
tive glomerulonephritis could be demonstrated [11]. We
therefore investigated the effects of the CXCR3 ligands IP-
10/CXCL10 and Mig/CXCL9 on MC and also found a con-
centration dependent increase of proliferation of MC after
stimulation with these chemokines. Interestingly, in con-
trast to the effect observed with SLC/CCL21 both IP-10/
CXCL10 and Mig/CXCL9 had no effect on Fas induced
apoptosis of MC.
The third chemokine receptor of interest was CCR1 since
our group has demonstrated functionally active
expression of CCR1 on human MC, inducible after stimu-
lation with a combination of the proinflammatory
cytokines TNF-α, IL-1β and IFN-γ [9]. Futhermore upreg-
ulation of CCR1 expression is also known in an animal
model for immune complex glomerulonephritis [38]. In
contrast to the effects observed with CCR7 and CXCR3 lig-
ands, stimulation of MC with the CCR1 ligand RANTES/
CCL5 had no effect on cell proliferation and apoptosis. In
this context an article of Topham et al. is of special inter-
est. This group demonstrated that CCR1 may have anti-
inflammatory functions since mice negative for CCR1
showed enhanced Th1 immune responses and worsened
histology in a model of nephrotoxic serum nephritis [39].
Our group showed in a model of horse apoferritin (HAF)-
induced glomerulonephritis that CC chemokine ligand 5/
RANTES chemokine antagonists aggravate glomerulone-
phrtis despite reduction of glomerular leukocyte infiltra-
tion. These findings were associated with an enhancing
effect of the CCL5/RANTES analogs on the macrophage
activation state in vitro and in vivo. The humoral response
and the Th1/Th2 balance in HAF-glomerulonephritis and
mesangial cell proliferation in vitro were not affected by
the CCL5/RANTES analogs [40]. Therefore also the effects
of the CCR1 blocker Met-RANTES were studied but
showed no influence on MC proliferation and apoptosis.
Conclusions
In summary it is tempting to speculate that the different
effects of SLC/CCL21 and IP-10/CXCL10 and Mig/CXCL9
on proliferation and apoptosis of MC represent special-
ized functions of chemokine receptos on non-immune
cells. CCR7 could be a chemokine receptor important for
the development of the glomerular architecture during
ontogenesis and for maintaining glomerular homeostasis
in adult human kidney. CXCR3 may have its main
functions important for mesangial expansion in mesangi-
oproliferative disease. In contrast, the chemokine receptor
CCR1 and its ligands RANTES/CCL5 and Met-RANTES
seems not to have a special impact for the regulation of
proliferation and apoptosis on MC. CCR1 may be impor-BMC Nephrology 2004, 5:8 http://www.biomedcentral.com/1471-2369/5/8
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tant for local immunomodulation especially in glomeru-
lar inflammation. The chemokines and their receptors we
have analyzed seem to be part of a complex system of fac-
tors which regulate proliferation and apoptosis in kidney
and therefore play a pivotal role in regulation of glomeru-
logenesis, during glomerular injury and in homeostatic
balance in the glomerulum. Studying these locally synthe-
sized chemokines and their interaction with correspond-
ing receptors on non-immune cells deserves further
investigation and will reveal novel chemokine/chemok-
ine receptor functions far beyond their orignal functions
in guiding inflammatory cells to sites of tissue injury.
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